Total Funding
60
74
Total FundingPost-IPO Equity raised
Growth Score 60 in past quarter
-13 pts
Heat Score 74 in past quarter
-10 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
34300
Niagen Bioscience is a provider of phytochemical standards, botanical materials, and research-grade materials for natural products industry.
- Rob Fried: CEOPast Role: Niagen Bioscience, President
- Ozan Pamir: CFO
About the Company
ChromaDex is a global nutraceutical company. They leverage their complementary business units to discover, acquire, develop, and commercialize patented and proprietary ingredient technologies that address the dietary supplement, food, beverage, skin care, and pharmaceutical markets. They utilize in-house chemistry, regulatory, and safety consulting
business units to develop commercially viable ingredients.